RELIVEN INJECTION

Țară: Australia

Limbă: engleză

Sursă: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredient activ:

MELOXICAM

Disponibil de la:

JUROX PTY LIMITED

INN (nume internaţional):

meloxicam(5mg/mL)

Forma farmaceutică:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Compoziție:

MELOXICAM UNGROUPED Active 5.0 mg/ml

Unități în pachet:

10mL; 20mL

Clasă:

VM - Veterinary Medicine

Grupul Terapeutică:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Zonă Terapeutică:

MUSCULOSKELETAL SYSTEM

Indicații terapeutice:

MUSCULOSKELETAL CONDITIONS | PAIN/INFLAMMATION ASSOCIATED WITH NONINF | POST SURGICAL PAIN | ARTHRITIS | ARTHROSIS | BURSITIS | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | OSTEITIS | OSTEOARTHRITIS | TENDON AND LIGAMENT SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE

Rezumat produs:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [PAIN/INFLAMMATION ASSOCIATED WITH NONINF, POST SURGICAL PAIN]; DOG: [MUSCULOSKELETAL CONDITIONS, PAIN/INFLAMMATION ASSOCIATED WITH NONINF, POST SURGICAL PAIN]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [PAIN/INFLAMMATION ASSOCIATED WITH NONINF, POST SURGICAL PAIN]; DOG: [MUSCULOSKELETAL CONDITIONS, PAIN/INFLAMMATION ASSOCIATED WITH NONINF, POST SURGICAL PAIN]; An anti-inflammatory injection for dogs and cats.This product is contraindicated for use in pregnant or lactating animals as no data has been established. This product is contraindicated for use in animals less than 6 weeks of age. This product is contraindicated for use in animals suffering from GI..

Statutul autorizaţiei:

Registered

Data de autorizare:

2023-07-01

Prospect

Reliven Injection labeling
MAY12
page 1/6
Vial label
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT -ONLY
REL1VEN
INJECTION
MELOXICAM 5 mg/mL
RLP
Approved
AN ANTI-INFLAMMATORY INJECTION FOR DOGS AND CATS
[10 mL][20 mL]
[Jurox logo]
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
DIRECTIONS FOR USE:
THIS PRODUCT IS CONTRAINDICATED FOR USE IN PREGNANT OR LACTATING
ANIMALS AS NO
DATA HAS BEEN ESTABLISHED.
THIS PRODUCT IS CONTRAINDICATED FOR USE IN ANIMALS LESS THAN 6 WEEKS
OF AGE.
DISCARD UNUSED PRODUCT 28 DAYS AFTER FIRST BROACHING VIAL.
DOGS:
0.4 mU10 kg single IV or SC.
CATS:
0.3 mL/5 kg single SC.
Store below 30°C (Room Temperature).
APVMA 65707/51670
B.
EXP.
Jurox Pty Limited
Infopest
Verified
Reliven Injection labeling
MAYI2
page 2/6
CARTON FRONT PANEL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
RELIVEN
INJECTION
Active constituent:
MELOXICAM 5 mg/mL
AN ANTI-INFLAMMATORY INJECTION FOR DOGS AND CATS
[10 mL]j20 mL]
[Jurox logo]
CARTON: SUBSIDIARY PANELS
For the alleviation of inflammation and pain in both acute and chronic
musculoskeletal
disorders and reduction of postoperative pain and inflammation
following orthopaedic and
soft tissue surgery in dogs.
For the reduction of pain after surgery and management of febrile
conditions with appropriate
antibiotics in cats.
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
DIRECTIONS FOR USE:
DISCARD UNUSED PRODUCT 28 DAYS AFTER FIRST BROACHING VIAL.
CONTRAINDICATIONS:
THIS PRODUCT IS CONTRAINDICATED FOR USE IN PREGNANT OR LACTATING
ANIMALS AS NO
DATA HAS BEEN ESTABLISHED.
THIS PRODUCT IS CONTRAINDICATED FOR USE IN ANIMALS LESS THAN 6 WEEKS
OF AGE.
THIS PRODUCT IS CONTRAINDICATED FOR USE IN ANIMALS SUFFERING FROM
GASTROINTESTINAL DISORDERS SUCH AS IRRITATION AND HAEMORRHAGE,
IMPAIRED
HEPATIC, CARDIAC OR RENAL FUNCTION AND HAEMORRHAGIC DISORDERS, OR
WHERE THERE
IS EVIDENCE OF INDIVIDUAL HYPERSENSITIVITY TO THE PRODUCT.
DOGS
Musculoskeletal disorders: a single subcutaneous injection at a dosag

Caracteristicilor produsului

RELIVEN INJECTION
Page 1 of 6
continued
ISSUED:
18 MARCH 2013
SAFETY DATA SHEET
SECTION 1: IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
PRODUCT NAME:
RELIVEN INJECTION
PRODUCT CODE:
504210 (20 mL)
RECOMMENDED USE:
An anti-inflammatory injection for dogs and cats.
COMPANY IDENTIFICATION:
Jurox Pty Limited
ADDRESS:
85 Gardiner Street
Rutherford NSW 2320
Australia
CUSTOMER CENTRE:
1800 023 312
NATIONAL POISONS INFORMATION CENTRE:
131126 (Australia-wide)
EMERGENCY TELEPHONE NUMBER:
1800 023 312 (9a.m. – 5p.m.)
SECTION 2: HAZARDS IDENTIFICATION
GHS HAZARD CLASSIFICATIONS:
EYE IRRITATION CATEGORY 2A
FLAMMABLE LIQUID CATEGORY 3
SKIN CORROSION/IRRITATION CATEGORY 2
GHS PICTOGRAMS*: FLAME EXCLAMATION MARK
SIGNAL WORD*:
WARNING
HAZARD STATEMENTS*:
H226
Flammable liquid and vapour.
H315
Causes skin irritation.
H319
Causes serious eye irritation.
PRECAUTIONARY STATEMENTS*:
PREVENTION
P201
Obtain special instructions before use
P202
Do not handle until label safety directions have been read and
understood
P210
Keep away from open flames - No smoking.
P233
Keep container tightly closed.
P240
Ground container and receiving equipment. (Production batches only.
Not
applicable to individual 10 or 20 mL vials)
P241
Use explosion-proof equipment. (Production batches only. Not
applicable to
individual 10 or 20 mL vials)
P242
Use only non-sparking tools. (Production batches only. Not applicable
to
individual 10 or 20 mL vials)
P243
Take precautionary measures against static discharge.
P264
Wash hands thoroughly after handling.
P280
Wear protective gloves and eye protection.
RELIVEN INJECTION
Page 2 of 6
continued
RESPONSE
P302+P352
IF ON SKIN: Wash with plenty of soap and water.
P303+P361
IF ON SKIN (or hair): Remove immediately all
+P353
contaminated clothing. Rinse skin with water.
P305+P351
IF IN EYES: Rinse cautiously with water for several minutes.
+P338
Remove contact lenses, if present and easy to do. Continue rinsing.
P332+P313
If skin irritation occurs: Get medical advice.
P337+P313
If eye irritation persists: Get medical

Fișa cu date de securitate

WWW.JUROX.COM.AU
Customer Service 1800 023 312
® Registered Trademark of Jurox Pty Ltd
TECHNICAL NOTES
RELIVEN
®
Injection
ACTIVE CONSTITUENTS
Meloxicam 5 mg/mL
ACTIONS
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the
oxicam class which acts by inhibition of prostaglandin synthesis,
thereby
exerting anti-inflammatory, anti-exudative, analgesic and antipyretic
effects. It reduces leukocyte infiltration into the inflamed tissue.
INDICATIONS
DOGS: For alleviation of inflammation and pain in both acute and
chronic musculoskeletal disorders. For reduction of post-operative
pain and inflammation following orthopaedic and soft tissue surgery in
dogs.
CATS: For reduction of pain after surgery. For management of febrile
conditions in combination with appropriate antibiotics.
CONTRAINDICATIONS
This product is contraindicated for use in pregnant or lactating
animals as no data has been established.
This product is contraindicated for use in animals less than 6 weeks
of age.
This product is contraindicated for use in animals suffering from
gastrointestinal disorders such as irritation and haemorrhage,
impaired hepatic, cardiac or renal function and haemorrhagic
disorders, or where there is evidence of individual hypersensitivity
to the product.
As for all NSAIDS, use in any animal less than 6 weeks of age or in
debilitated aged animals may involve additional risk. If use in
such animals cannot be avoided careful clinical management may be
required.
WWW.JUROX.COM.AU
Customer Service 1800 023 312
® Registered Trademark of Jurox Pty Ltd
TECHNICAL NOTES
PRECAUTIONS
CATS: Reliven® Injection should be used as a single dose of 0.3 mg
meloxicam / kg bodyweight. Safety trials have demonstrated that
meloxicam when administered subcutaneously at 0.3 mg/kg at 24 hour
intervals for 3 consecutive days in cats, resulted in no side
effects in trial animals.
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics
and substances with high protein binding may compete
for binding and thus lead to toxic effects.